STRIDES PHARMA SCIENCE LIMITED (STAR)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 986.37 929.99 999.43 1,037.67 1,084.04 1,087.51 1,201.11 1,153.67 1,190.39 1,119.74 1,220.83 1,194.65
YOY Revenue Growth % 13.9% -1.07% 11.41% 19.98% 9.9% 16.94% 20.18% 11.18% 9.81% 2.96% 1.64% 3.55%
Other Income 27.12 8.65 35.85 8.75 -13.55 12.72 28.41 5.62 11.98 8.58 27.14 106.86
Total Income 1,013.49 938.64 1,035.28 1,046.42 1,070.49 1,100.22 1,229.52 1,159.28 1,202.37 1,128.32 1,247.97 1,301.51
Total Expenses + 698.52 648.30 770.51 797.74 791.91 814.29 916.23 939.81 1,071.71 998.01 1,085.03 1,052.70
Cost of Materials Consumed 268.41 269.85 342.30 375.13 353.84 364.21 448.85 476.58 269.73 260.58 429.76 459.71
Employee Benefit Expense 175.66 167.53 199.93 184.49 199.17 212.17 219.41 215.64 222.86 225.52 226.78 229.54
Other Expenses 254.45 210.92 228.28 238.12 238.91 237.91 247.97 247.59 250.69 231.86 247.22 266.22
Operating Profit 287.85 281.69 228.92 239.93 292.12 273.22 284.88 213.86 118.69 121.73 135.80 141.94
OPM % 29.2% 30.3% 22.9% 23.1% 26.9% 25.1% 23.7% 18.5% 10% 10.9% 11.1% 11.9%
Profit Before Tax + 33.89 33.25 -114.64 61.99 78.20 96.98 127.67 112.89 103.25 121.94 154.17 245.51
Tax Expense 47.69 42.61 34.81 7.93 67.76 28.67 34.01 22.85 17.63 16.35 22.64 37.38
Tax % 140.7% 128.2% - 12.8% 86.6% 29.6% 26.6% 20.2% 17.1% 13.4% 14.7% 15.2%
Profit After Tax -13.80 -9.36 -149.46 54.06 10.44 68.31 93.66 90.04 85.62 105.59 131.52 208.12
EPS (Basic) -1.06 -0.79 -14.54 5.43 1.98 7.64 10.14 9.56 8.92 10.81 13.84 21.93

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 4,565.34 4,051.12 3,688.39 3,070.25 3,315.87 2,751.97 3,011.68
YOY Revenue Growth % 12.69% 9.83% 20.13% -7.41% 20.49% -8.62% -
Other Income 58.72 39.70 90.33 131.99 51.43 53.11 45.43
Total Income 4,624.06 4,090.83 3,778.72 3,202.24 3,367.30 2,805.08 3,057.11
Total Expenses + 4,203.63 3,008.47 3,073.00 2,678.97 2,738.67 2,133.94 2,092.97
Cost of Materials Consumed 1,475.89 1,341.11 1,441.68 1,090.93 1,390.42 1,020.35 1,002.05
Employee Benefit Expense 862.76 751.13 732.02 646.91 550.15 442.56 442.58
Other Expenses 919.80 916.23 899.30 941.13 798.10 671.03 648.34
Operating Profit 361.70 1,042.66 615.39 391.28 577.20 618.03 918.71
OPM % 7.9% 25.7% 16.7% 12.7% 17.4% 22.5% 30.5%
Profit Before Exceptional 420.42 247.84 16.12 -297.88 329.91 239.59 122.99
Exceptional Items 64.66 -189.05 -17.03 -243.83 43.35 -77.68 -2.62
Profit Before Tax + 485.08 58.79 -0.92 -541.70 373.26 161.91 120.37
Tax Expense -3,112.43 153.11 211.41 -67.45 115.53 131.33 -209.50
Tax % -641.6% 260.4% - - 31% 81.1% -174%
Profit After Tax 3,597.51 -94.31 -212.33 -474.25 257.73 30.58 329.87
EPS (Basic) 390.54 -7.76 -22.49 -51.28 29.96 4.06 36.25

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 2,949.81 2,870.76 3,395.06 0.00 0.00 0.00 0.00
Property, Plant & Equipment 880.69 878.67 1,324.29 0.00 0.00 0.00 0.00
Capital Work in Progress 99.65 79.88 48.26 0.00 0.00 0.00 0.00
Non-Current Investments 329.03 7.63 53.04 0.00 0.00 0.00 0.00
Goodwill 546.57 529.41 513.76 0.00 0.00 0.00 0.00
Other Intangible Assets 460.85 445.10 460.37 0.00 0.00 0.00 0.00
Current Assets + 3,098.91 2,969.00 3,135.25 0.00 0.00 0.00 0.00
Inventories 1,277.57 1,126.24 1,146.51 0.00 0.00 0.00 0.00
Trade Receivables 1,202.94 1,141.87 1,299.40 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 112.56 161.02 303.50 0.00 0.00 0.00 0.00
Current Investments 69.50 105.76 50.84 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 92.16 91.90 90.30 0.00 0.00 0.00 0.00
Other Equity 2,459.67 2,033.66 2,121.96 0.00 0.00 0.00 0.00
Non-Current Liabilities 870.74 888.79 1,475.34 0.00 0.00 0.00 0.00
Current Liabilities 2,591.52 2,879.26 2,990.20 0.00 0.00 0.00 0.00
Total Liabilities 3,462.26 3,768.05 4,465.54 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 684.37 701.07 44.41 -257.82 0.00 0.00 0.00
Cash from Investing Activities -89.69 -150.25 302.47 -118.73 0.00 0.00 0.00
Cash from Financing Activities -642.58 -693.32 -213.92 421.32 0.00 0.00 0.00
Net Increase/Decrease in Cash -48.43 -142.48 132.77 44.90 0.00 0.00 0.00